191 related articles for article (PubMed ID: 27828824)
1. Outcome, Treatment, and Treatment Failures in Patients Suffering Localized Embryonal Paratesticular Rhabdomyosarcoma: Results From the "Cooperative Weichteilsarkom Studiengruppe" Trials CWS-86, -91, -96, and -2002P.
Seitz G; Fuchs J; Martus P; Klingebiel T; Leuschner I; Schuck A; Dantonello TM; Koscielniak E;
Ann Surg; 2016 Dec; 264(6):1148-1155. PubMed ID: 27828824
[TBL] [Abstract][Full Text] [Related]
2. Treatment and outcome of patients with localized intrathoracic and chest wall rhabdomyosarcoma: a report of the Cooperative Weichteilsarkom Studiengruppe (CWS).
Fuchs J; Urla C; Sparber-Sauer M; Schuck A; Leuschner I; Klingebiel T; Blumenstock G; Seitz G; Koscielniak E
J Cancer Res Clin Oncol; 2018 May; 144(5):925-934. PubMed ID: 29464349
[TBL] [Abstract][Full Text] [Related]
3. Impact of hemiscrotectomy on outcome of patients with embryonal paratesticular rhabdomyosarcoma: results from the Cooperative Soft Tissue Sarcoma Group Studies CWS-86, 91, 96 and 2002P.
Seitz G; Dantonello TM; Kosztyla D; Klingebiel T; Leuschner I; Fuchs J; Koscielniak E;
J Urol; 2014 Sep; 192(3):902-7. PubMed ID: 24631108
[TBL] [Abstract][Full Text] [Related]
4. Treatment of children with nonmetastatic paratesticular rhabdomyosarcoma: results of the Malignant Mesenchymal Tumors studies (MMT 84 and MMT 89) of the International Society of Pediatric Oncology.
Stewart RJ; Martelli H; Oberlin O; Rey A; Bouvet N; Spicer RD; Godzinski J; Stevens MC;
J Clin Oncol; 2003 Mar; 21(5):793-8. PubMed ID: 12610176
[TBL] [Abstract][Full Text] [Related]
5. Treatment and outcome of the patients with rhabdomyosarcoma of the biliary tree: Experience of the Cooperative Weichteilsarkom Studiengruppe (CWS).
Urla C; Warmann SW; Sparber-Sauer M; Schuck A; Leuschner I; Klingebiel T; Blumenstock G; Seitz G; Koscielniak E; Fuchs J
BMC Cancer; 2019 Oct; 19(1):945. PubMed ID: 31610788
[TBL] [Abstract][Full Text] [Related]
6. Controversies in the management of paratesticular rhabdomyosarcoma: is staging retroperitoneal lymph node dissection necessary for adolescents with resected paratesticular rhabdomyosarcoma?
Wiener ES; Anderson JR; Ojimba JI; Lobe TE; Paidas C; Andrassy RJ; Raney RB; Qualman SJ; Donaldson SS; Maurer HM; Link MP; Crist WM; Grier HE
Semin Pediatr Surg; 2001 Aug; 10(3):146-52. PubMed ID: 11481652
[TBL] [Abstract][Full Text] [Related]
7. Paratesticular rhabdomyosarcoma: report from the Italian and German Cooperative Group.
Ferrari A; Bisogno G; Casanova M; Meazza C; Piva L; Cecchetto G; Zanetti I; Pilz T; Mattke A; Treuner J; Carli M
J Clin Oncol; 2002 Jan; 20(2):449-55. PubMed ID: 11786573
[TBL] [Abstract][Full Text] [Related]
8. Lymph node management in patients with paratesticular rhabdomyosarcoma: a population-based analysis.
Dang ND; Dang PT; Samuelian J; Paulino AC
Cancer; 2013 Sep; 119(17):3228-33. PubMed ID: 23744806
[TBL] [Abstract][Full Text] [Related]
9. Treatment and outcome of patients with thoracic tumors of the Ewing sarcoma family: A report from the Cooperative Weichteilsarkom Studiengruppe CWS-81, -86, -91, -96, and -2002P trials.
Seitz G; Urla C; Sparber-Sauer M; Schuck A; Vokuhl C; Blank B; Klingebiel T; Kazanowska B; Fuchs J; Koscielniak E
Pediatr Blood Cancer; 2019 Mar; 66(3):e27537. PubMed ID: 30421578
[TBL] [Abstract][Full Text] [Related]
10. Impact of local control and surgical lymph node evaluation in localized paratesticular rhabdomyosarcoma: A report from the Children's Oncology Group Soft Tissue Sarcoma Committee.
Routh JC; Dasgupta R; Chi YY; Shnorhavorian M; Tian J; Walterhouse DO; Breneman J; Wolden SL; Arndt CA; Hawkins DS; Rodeberg DA
Int J Cancer; 2020 Dec; 147(11):3168-3176. PubMed ID: 32525556
[TBL] [Abstract][Full Text] [Related]
11. Significance of fusion status, Oberlin risk factors, local and maintenance treatment in pediatric and adolescent patients with metastatic rhabdomyosarcoma: Data of the European Soft Tissue Sarcoma Registry SoTiSaR.
Heinz AT; Schönstein A; Ebinger M; Fuchs J; Timmermann B; Seitz G; Vokuhl C; Münter M; Pajtler KW; Stegmaier S; von Kalle T; Kratz CP; Ljungman G; Juntti H; Klingebiel T; Koscielniak E; Sparber-Sauer M;
Pediatr Blood Cancer; 2024 Jan; 71(1):e30707. PubMed ID: 37814424
[TBL] [Abstract][Full Text] [Related]
12. The impact of local control in the treatment of type II/III pleuropulmonary blastoma. Experience of the Cooperative Weichteilsarkom Studiengruppe (CWS).
Sparber-Sauer M; Seitz G; Kirsch S; Vokuhl C; Leuschner I; Dantonello TM; Scheer M; von Kalle T; Ljungman G; Bielack SS; Klingebiel T; Fuchs J; Koscielniak E;
J Surg Oncol; 2017 Feb; 115(2):164-172. PubMed ID: 28103635
[TBL] [Abstract][Full Text] [Related]
13. Paratesticular rhabdomyosarcoma in children and adolescents-Outcome and patterns of relapse when utilizing a nonsurgical strategy for lymph node staging: Report from the International Society of Paediatric Oncology (SIOP) Malignant Mesenchymal Tumour 89 and 95 studies.
Rogers T; Minard-Colin V; Cozic N; Jenney M; Merks JHM; Gallego S; Devalck C; Gaze MN; Kelsey A; Oberlin O; Stevens M; Spicer RD; Bergeron C; Martelli H
Pediatr Blood Cancer; 2017 Sep; 64(9):. PubMed ID: 28205365
[TBL] [Abstract][Full Text] [Related]
14. The role of retroperitoneal lymphadenectomy in localized paratesticular rhabdomyosarcoma.
Goldfarb B; Khoury AE; Greenberg ML; Churchill BM; Smith CR; McLorie GA
J Urol; 1994 Aug; 152(2 Pt 2):785-7. PubMed ID: 8022014
[TBL] [Abstract][Full Text] [Related]
15. Treatment and outcome of patients suffering from perineal/perianal rhabdomyosarcoma: results from the CWS trials--retrospective clinical study.
Fuchs J; Dantonello TM; Blumenstock G; Kosztyla D; Klingebiel T; Leuschner I; Schuck A; Niggli FK; Koscielniak E; Seitz G
Ann Surg; 2014 Jun; 259(6):1166-72. PubMed ID: 24045440
[TBL] [Abstract][Full Text] [Related]
16. Rhabdomyosarcoma diagnosed in the first year of life: Localized, metastatic, and relapsed disease. Outcome data from five trials and one registry of the Cooperative Weichteilsarkom Studiengruppe (CWS).
Sparber-Sauer M; Stegmaier S; Vokuhl C; Seitz G; von Kalle T; Scheer M; Münter M; Bielack SS; Weclawek-Tompol J; Ladenstein R; Niggli F; Ljungman G; Fuchs J; Hettmer S; Koscielniak E; Klingebiel T;
Pediatr Blood Cancer; 2019 Jun; 66(6):e27652. PubMed ID: 30762282
[TBL] [Abstract][Full Text] [Related]
17. Initial patient characteristics can predict pattern and risk of relapse in localized rhabdomyosarcoma.
Dantonello TM; Int-Veen C; Winkler P; Leuschner I; Schuck A; Schmidt BF; Lochbuehler H; Kirsch S; Hallmen E; Veit-Friedrich I; Bielack SS; Niggli F; Kazanowska B; Ladenstein R; Wiebe T; Klingebiel T; Treuner J; Koscielniak E
J Clin Oncol; 2008 Jan; 26(3):406-13. PubMed ID: 18202417
[TBL] [Abstract][Full Text] [Related]
18. Surgical management of paratesticular rhabdomyosarcoma: A consensus opinion from the Children's Oncology Group, European paediatric Soft tissue sarcoma Study Group, and the Cooperative Weichteilsarkom Studiengruppe.
Rogers TN; Seitz G; Fuchs J; Martelli H; Dasgupta R; Routh JC; Hawkins DS; Koscielniak E; Bisogno G; Rodeberg DA
Pediatr Blood Cancer; 2021 Apr; 68(4):e28938. PubMed ID: 33522706
[TBL] [Abstract][Full Text] [Related]
19. Improvements in the Treatment of Patients Suffering from Bladder-Prostate Rhabdomyosarcoma: A Report from the CWS-2002P Trial.
Seitz G; Fuchs J; Sparber-Sauer M; Leuschner I; Godzinski J; Klingebiel T; Schuck A; Martus P; Dantonello TM; Koscielniak E
Ann Surg Oncol; 2016 Nov; 23(12):4067-4072. PubMed ID: 27387676
[TBL] [Abstract][Full Text] [Related]
20. Cooperative trial CWS-91 for localized soft tissue sarcoma in children, adolescents, and young adults.
Dantonello TM; Int-Veen C; Harms D; Leuschner I; Schmidt BF; Herbst M; Juergens H; Scheel-Walter HG; Bielack SS; Klingebiel T; Dickerhoff R; Kirsch S; Brecht I; Schmelzle R; Greulich M; Gadner H; Greiner J; Marky I; Treuner J; Koscielniak E
J Clin Oncol; 2009 Mar; 27(9):1446-55. PubMed ID: 19224858
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]